fNIRS neurofeedback with motor imagery to improve balance and walking in Parkinson's disease
Official title: The Novel Application of fNIRS-based Neurofeedback to Enhance Effects of Motor Imagery on Balance and Gait Performance in Individuals With Parkinson's Disease
Run by National Yang Ming Chiao Tung University · NCT05800470 · Data updated 2026-11-12
This will see if adding fNIRS-based neurofeedback to motor imagery can improve balance and walking in people with Parkinson's disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 85 Years |
| Sex | All |
| Enrollment | 93 (estimated) |
| Sponsor | National Yang Ming Chiao Tung University Academic / other |
| Locations | 1 site (Taipei, None Selected) |
| Status | Recruiting |
| Started | March 19, 2025 |
| Main results expected | August 1, 2025 |
| Study ends | August 1, 2025 |
| Registry record updated | August 7, 2025 |
| Trial ID | NCT05800470 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 40–85 with idiopathic Parkinson's disease (Hoehn and Yahr stage <4), stable medical treatment, able to walk independently for at least 10 minutes, and without major cognitive impairment or very low motor imagery ability.
✕Probably not a fit
Patients unlikely to benefit include those with significant cognitive impairment (MMSE <24), very low motor imagery ability (KVIQ <25), deep brain stimulation or brain metal implants, other neurological or psychiatric disorders, or who cannot attend in-person sessions.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The study has two parts: a cross-sectional comparison of motor imagery ability and the effects of fatigue in people with Parkinson's disease versus age-matched healthy controls, and a randomized controlled trial testing interventions in people with Parkinson's. In the RCT, participants are randomly assigned to neurofeedback-plus-motor-imagery, motor-imagery-only, or motor training groups and receive 12 sessions over four weeks. Neurofeedback uses functional near-infrared spectroscopy (fNIRS) during 20-minute motor imagery sessions, followed by balance and gait training, while outcomes (Mini-BEST, TUG, gait measures) are measured before, after, and at follow-up. The cross-sectional part examines general and induced fatigue using validated scales and correlates fatigue levels with motor imagery ability.
Why it matters
Potential benefit: If successful, this approach could improve balance and gait and potentially reduce fall risk in people with Parkinson's disease.
How similar studies have gone: Related neurofeedback and motor imagery studies in Parkinson's have shown promising but preliminary results in small samples, so fNIRS-based neurofeedback for gait and balance remains relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Part 1 Additional Inclusion Criteria for PD: 1. diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4; 2. stable medical condition; 3. capability of walking independently without walking devices. Exclusion Criteria: 1. cognitive impairment indicated by MMSE score \< 24; 2. motor imagery ability indicated by KVIQ score \< 25; 3. unable recognize 26 letters in the English alphabet 4. history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation); 5. diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression); 6. using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months. Part 2 Inclusion Criteria: 1. aged 40-85 y/o; 2. diagnosis of idiopathic PD by neurologist with Hoehn and Yahr stage \< 4; 3. stable medical condition; 4. capability of walking independently for 10 minutes, which is the time needed for imagery walking training in order to eliminate the possible influence of physical fatigue. Exclusion Criteria: 1. cognitive impairment indicated by MMSE score \< 24; 2. history of diseases or conditions known to interfere with participating this study (e.g. epilepsy, metal implants in the brain, or deep brain stimulation); 3. diagnosis of any other neurological disease or psychiatric disorder (e.g. stroke, anxiety disorder, or depression); 4. using central nervous system medications other than for PD, e.g. antiepileptic drugs in recent 3 months.
Where it's running
-
National Yang Ming Chiao Tung University
Taipei, None Selected, Taiwan Recruiting
Study contacts
- Principal investigator: Ray-Yau Wang — National Yang Ming Chiao Tung University
- Study coordinator: Ray-Yau Wang
- Email: rywang@nycu.edu.tw
- Phone: +88628267210
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.